N

    National Research Corp (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $20.94
    -0.91 (-4.16%)

    Market Cap: $463.60M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(14/18)
    Avg Surprise
    +1.81%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.21
    Range$0.21 - $0.21
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00-100.0%
    60d ago$0.00-100.0%
    30d ago$0.21+0.0%
    7d ago$0.21+0.0%
    Current$0.21
    Revenue Consensus
    $36M
    Range$36M - $36M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-$0.21---
    Jun 26
    Reported Jul 28
    		$0.31$0.14+121.43%Beat+3200.0%
    Mar 26
    Reported Apr 28
    		$0.14N/AN/ABeat-44.0%
    Dec 25
    Reported Feb 3
    		$0.08$0.00N/ABeat-70.7%
    Sep 25
    Reported Oct 27
    		$0.18$0.00N/ABeat-24.6%
    Jun 25
    Reported Jul 28
    		$-0.01$0.00N/AMiss-103.9%
    Mar 25
    Reported Apr 28
    		$0.25N/AN/ABeat-5.1%
    Dec 24
    Reported Feb 11
    		$0.28N/AN/ABeat-22.0%
    Sep 24
    Reported Oct 25
    		$0.24N/AN/ABeat-25.2%
    Jun 24
    Reported Aug 6
    		$0.26N/AN/ABeat-11.0%
    Mar 24
    Reported May 7
    		$0.27N/AN/ABeat-5.3%
    Dec 23
    Reported Feb 13
    		$0.36$0.36+0.00%Beat+33.3%
    Sep 23
    Reported Nov 7
    		$0.32$0.32+0.00%Beat-3.0%
    Jun 23
    Reported Aug 1
    		$0.29$0.29+0.00%Beat-12.1%
    Mar 23
    Reported May 2
    		$0.28N/AN/ABeat-17.6%
    Dec 22
    Reported Feb 14
    		$0.27N/AN/ABeat-28.9%
    Sep 22
    Reported Nov 1
    		$0.33N/AN/ABeat-13.2%
    Jun 22
    Reported Aug 2
    		$0.33N/AN/ABeat-5.7%
    Mar 22
    Reported May 3
    		$0.34N/AN/ABeat-5.6%
    Dec 21
    Reported Feb 8
    		$0.38N/AN/ABeat+18.8%
    Sep 21
    Reported Nov 2
    		$0.38N/AN/ABeat+2.7%
    Jun 21
    Reported Aug 3
    		$0.35N/AN/ABeat+16.7%
    Mar 21
    Reported May 4
    		$0.36N/AN/ABeat-21.7%
    Dec 20
    Reported Feb 9
    		$0.32N/AN/ABeat-5.9%
    Sep 20
    Reported Nov 3
    		$0.37N/AN/ABeat+19.4%
    Jun 20
    Reported Aug 4
    		$0.30N/AN/ABeat+3.4%
    Mar 20
    Reported May 5
    		$0.46N/AN/ABeat+43.8%
    Dec 19
    Reported Feb 11
    		$0.34$0.30+13.33%Beat+13.3%
    Sep 19
    Reported Nov 5
    		$0.31$0.29+6.90%Beat+14.8%
    Jun 19
    Reported Aug 6
    		$0.29$0.26+11.54%Beat+3.6%
    Mar 19
    Reported May 7
    		$0.32$0.31+3.23%Beat+10.3%
    Dec 18
    Reported Feb 12
    		$0.30N/A-71.43%Miss+100.0%
    Sep 18
    Reported Nov 6
    		$0.27N/A-72.45%Miss+68.8%
    Jun 18
    Reported Aug 7
    		$0.28$0.22+27.27%Beat+21.7%
    Mar 18
    Reported May 1
    		$0.29$0.25+16.00%Beat+11.5%
    Dec 17
    Reported Feb 13
    		$0.15$0.22-31.82%Miss-37.5%
    Sep 17
    Reported Nov 7
    		$0.16$0.21-23.81%Miss-15.8%
    Jun 17
    Reported Aug 1
    		$0.23$0.20+15.00%Beat-
    Mar 17
    Reported May 2
    		$0.26$0.24+8.33%Beat-
    Dec 16
    Reported Feb 21
    		$0.24$0.22+9.09%Beat-
    Sep 16
    Reported Nov 1
    		$0.19$0.19+0.00%Beat-

    Dividends

    Dividend Metrics

    Yield2.87%
    Annual/Share$0.60
    Payout Ratio44.75%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR-14.77%
    5Y CAGR+19.88%
    View NRC's full dividend history

    Key Metrics

    Valuation
    P/E Ratio29.33EV/EBITDA24.56x
    Price/FCF21.30xFCF Yield4.70%
    Profitability
    Profit Margin4.18%Operating Margin-0.22%
    ROE42.00%ROIC9.87%
    Financial Health
    Debt/Equity13.75xInterest Coverage2.71x
    Current Ratio0.65xQuick Ratio0.65x
    Trading Statistics
    Beta0.37Avg Volume123.28K
    52-Week High$23.6852-Week Low$10.74

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.87
    SMA 20$21.24
    SMA 50$21.19
    SMA 200$18.26
    EMA 10$21.64
    EMA 20$21.42
    EMA 50$20.86
    EMA 200$18.43

    MACD

    Line: 0.29Signal: 0.30Hist: -0.02

    ADX

    ADX: 13.5+DI: 19.7-DI: 22.6

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down8.0
    PSAR$18.73

    Bollinger Bands

    Upper Band$23.05
    Lower Band$19.44
    %B Position1699%(Upper)
    Band Width0.42

    RSI (14-Day)

    Neutral
    46.4

    Momentum Oscillators

    Stoch %K56.6
    Stoch %D66.1
    Williams %R-64.1
    ROC (10d)-3.8%
    Momentum-0.83
    CCI (20d)-10.8
    MFI (14d)57.7

    Volatility Measures

    ATR (14d)$0.99(4.7%)
    StdDev (20d)0.90
    Hist Vol34.0%(Moderate)

    Volume Flow

    VWAP$21.11
    OBV6.2M
    AD Line-36.8M
    CMF (20d)0.058

    Volume Metrics

    Avg Vol (20d)124.2K
    Vol Ratio0.8x
    VWMA (20d)$21.25

    Pivot Points

    R3$22.38
    R2$22.25
    R1$22.05
    Pivot Point$21.93
    S1$21.73
    S2$21.60
    S3$21.40

    Advanced Oscillators

    TSI9.74
    Ultimate Osc47.2
    KST44.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M$37.95M
    Cost of Revenue$0$0$16.08M$0$0$0$14.35M$0$0$0$13.79M$0
    Gross Profit$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M$37.95M
    Operating Expenses$38.63M$29.23M$30.52M$26.87M$32.45M$24.95M$27.32M$27.84M$26.16M$26.55M$26.29M$27.99M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$22.95M$13.42M$14.44M$12.27M$17.73M$10.36M$11.45M$10.99M$11.22M$11.25M$11.07M$11.80M
    Operating Income$-3,238,000$5.57M$4.67M$7.74M$1.59M$8.60M$9.59M$7.98M$8.87M$8.76M$11.71M$9.96M
    Interest Income$20,000$35,000$30,000$41,000$21,000$19,000$22,000$34,000$25,000$44,000$41,000$256,000
    Interest Expense$1.32M$1.25M$1.37M$1.46M$1.03M$899,000$729,000$706,000$555,000$605,000$269,000$160,000
    Income Before Tax$-4,537,000$4.38M$3.27M$6.27M$581,000$7.72M$8.88M$7.30M$8.32M$8.19M$11.47M$10.04M
    Income Tax Expense$-1,254,000$1.16M$1.47M$2.15M$687,000$1.94M$2.31M$1.61M$2.15M$1.83M$2.61M$2.16M
    Net Income$-3,283,000$3.22M$1.80M$4.12M$-106,000$5.79M$6.56M$5.69M$6.17M$6.36M$8.86M$7.88M
    EBITDA$-1,088,000$7.79M$6.78M$9.92M$3.37M$10.16M$11.10M$9.53M$10.38M$10.21M$13.13M$11.50M
    EBIT$-3,236,000$5.60M$4.61M$7.69M$1.59M$8.60M$9.58M$7.97M$8.85M$8.76M$11.70M$9.94M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NRC

    News

    Wall Street Zen Downgrades National Research (NASDAQ:NRC) to Hold

    Wall Street Zen has downgraded National Research (NASDAQ:NRC) from "Buy" to "Hold," following a separate downgrade to "Sell" by Weiss Ratings. Despite these downgrades, MarketBeat's consensus rating remains "Hold" with a $26.00 price target. National Research recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue.

    MarketBeat•8/15/26•
    Somewhat-Bearish

    National Research Corporation (NRC) stock price, news, quote and history

    This article provides a detailed overview of NRC Health (NRC) stock, including its current price, historical data, key financial metrics, and analyst ratings. It highlights the company's services in healthcare analytics and patient experience improvement, and compares its performance against the S&P 500. The article also includes information about the company's recent earnings, leadership, and industry position.

    Yahoo Finance UK•8/13/26•
    Somewhat-Bullish

    Record Backlog Powers NRC Health’s (NRC) Upward Potential

    Long Cast Advisers, an independent investment adviser, highlighted NRC Health (NASDAQ: NRC) in its Q2 2026 investor letter, noting the company's strong performance, recent management changes, and a record backlog. Despite its positive outlook, the firm suggests that certain AI stocks may offer greater upside potential with less risk. NRC Health provides analytics to healthcare organizations and recently announced its largest contract in company history.

    Yahoo! Finance Canada•8/10/26•
    Bullish

    National Research Corp (NRC) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for National Research Corp (NRC), noting its current earnings forecast score is 8.00, ranking 37th in its industry. Based on one analyst's rating, NRC is given a "Buy" recommendation with a target price indicating a 33.54% upside. The report includes peer comparisons but states that relevant financial forecasting data for EPS, Revenue, Net Profit, and EBIT has not yet been disclosed by the company.

    TradingKey•8/8/26•
    Bullish

    National Research Corp (NRC) Institutional Confidence

    National Research Corp (NRC) has an institutional shareholding score of 5.00, placing it 95th out of 159 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 53.51%, marking a 9.20% increase quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 860.95K shares, which represents 4.30% of outstanding shares.

    TradingKey•7/31/26•
    Neutral

    Frequently Asked Questions About NRC

    What is NRC's current dividend yield?
    National Research Corp (NRC) has a current dividend yield of 2.87%.
    Does NRC pay dividends?
    Yes, National Research Corp pays dividends with a current yield of 2.87%.
    What is NRC's P/E ratio?
    National Research Corp has a price-to-earnings (P/E) ratio of 29.33.
    What is NRC's market cap?
    National Research Corp (NRC) has a market capitalization of $463.60M with a current stock price of $20.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In